Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1702-1707

  Kamath, Arun T ^a   Feng, Carl G ^a   Macdonald, Murdo ^a,c   Briscoe, Helen ^a,b   Britton, Warwick J ^a,b  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DNA VACCINE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033063963     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.67.4.1702-1707.1999     Document Type: Article

References (39)

1. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544.
2. Andersen, P., A. B. Andersen, A. L. Sorensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
3. Andersen, P., D. Askgaard, A. Gottschau, J. Bennedsen, S. Nagai, and I. Heron. 1992. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand. J. Immunol. 36:823-831.
4. Bloom, B. R., and C. J. L. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055-1064.
5. Boesen, H., B. N. Jensen, T. Wilcke, and P. Andersen. 1995. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 63:1491-1497.
6. Borremans, M., L. De Wit, G. Volckaert, J. Ooms, J. De Bruyn, K. Huygen, J.-P. Van Vooren, M. Stelandre, R. Verhofstadt, and J. Content. 1989. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene at Mycobacterium tuberculosis. Infect. Immun. 57:3123-3130.
7. Boyle, J. S., J. L. Brady, and A. M. Lew. 1998. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408-411.
8. Boyle, J. S., A. Silva, J. L. Brady, and A. M. Lew. 1997. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl Acad. Sci. USA 94:14626-14631.
9. Colditz, G. A., T. F. Brewer, C. S. Berkley, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature. JAMA 271:698-702.
10. + cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1739-1746.
11. + T-cell priming against the identified peptides after DNA-vaccination of mice. Vaccine 16:692-697.
12. Feng, C. G. Unpublished data.
13. Flynn, J.-A. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
14. Haddad, D., S. Liljeqvist, S. Stahl, I. Andersson, P. Perlmann, K. Berzins, and N. Ahlborg. 1997. Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice. FEMS Immunol. Med. Microbiol. 18:193-202.
15. Hedstrom, R. C., D. L. Doolan, R. Wang, M. J. Gardner, A. Kumar, M. Sedegah, R. A. Gramzinski, J. B. Sacci, Jr., Y. Charoenvit, W. R. Weiss, M. Margalith, J. A. Norman, P. Hobart, and S. L. Hoffman. 1997. The development of a multivalent DNA vaccine for malaria. Springer Semin. Immunopathol. 19:147-159.
16. Hedstrom, R. C., D. L. Doolan, R. B. Wang, A. Kumar, J. B. Sacci, M. J. Gardner, J. C. Aguiar, Y. Charoenvit, M. Sedegah, J. A. Tine, M. Margalith, P. Hobart, and S. L. Hoffman. 1998. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. Int. J. Mol. Med. 2:29-38.
17. Hoffman, S. L., D. L. Doolan, M. Sedegah, J. C. Aguiar, R. Wang, A. Malik, R. A. Gramzinski, W. R. Weiss, P. Hobart, J. A. Norman, M. Margalith, and R. C. Hedstrom. 1997. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine 15:842-845.
18. Horwitz, M. A., B.-W. E. Lee, B. J. Dillon, and G. Harth. 1995 Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92: 1530-1534.
19. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J. P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
20. Iwasaki, A., B. J. Stiernholm, A. K. Chan, N. L. Berinstein, and B. H. Barber. 1997. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:4591-4601.
21. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:270-275.
22. Launois, P., R. DeLeys, M. N. Niang, A. Drowart, M. Andrien, P. Dierckx, J.-L. Cartel, J.-L. Sarthou, J.-P. Van Vooren, and K. Huygen. 1994. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62:3679-3687.
23. Martin, E. Unpublished data.
24. Montgomery, D. L., K. Huygen, A. M. Yawman, R. R. Deck, C. M. DeWitt, J. Content, M. A. Liu, and J. B. Ulmer. 1997. Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA. Cell. Mol. Biol. 43:285-292.
25. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777-785.
26. Okada, E., S. Sasaki, N. Ishii, I. Aoki, T. Yasuda, K. Nishioka, J. Fukushima, J. Miyazaki, B. Wahren, and K. Okuda. 1997. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:3638-3647.
27. Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138:293-298.
28. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481-1497.
29. Roberts, A. D., M. G. Sonnenberg, D. J. Ordway, S. K. Furney, P. J. Brennan, J. T. Belisle, and I. M. Orme. 1995. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85:502-508.
30. Roche, P. W., C. G. Feng, and W. J. Britton. 1996. Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. Scand. J. Immunol. 43:662-670.
31. Roche, P. W., P. W. Peake, H. Billman-Jacobe, T. Doran, and W. J. Britton. 1994. T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect. Immun. 62: 5319-5326.
32. Roche, P. W., J. A. Triccas, D. T. Avery, T. Fifis, H. Billman-Jacobe, and W. J. Britton. 1994. Differential T-cell responses to mycobacterial secreted proteins distinguish between vaccination with bacille Calmette Guerin (BCG) and infection with Mycobacterium tuberculosis. J. Infect. Dis. 170: 1326-1330.
33. Roche, P. W., N. Winter, J. A. Triccas, C. G. Feng, and W. J. Britton. 1996. Expression of Mycobacterium tuberculosis MPT64 in recombinant Mycosmegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin. Exp. Immunol. 103:226-232.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
36. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397-402.
37. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:888-892.
38. Xiang, Z., and H. C. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135.
39. Zhu, X., N. Venkataprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier. 1997. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:5921-5926.